» Articles » PMID: 38161720

Mitochondrial DNA Oxidation, Methylation, and Copy Number Alterations in Major and Bipolar Depression

Overview
Specialty Psychiatry
Date 2024 Jan 1
PMID 38161720
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mood disorders are common disabling psychiatric disorders caused by both genetic and environmental factors. Mitochondrial DNA (mtDNA) modifications and epigenetics are promising areas of research in depression since mitochondrial dysfunction has been associated with depression. In this study we aimed to investigate the mtDNA changes in depressive disorder (MDD) and bipolar disorder (BD).

Methods: Displacement loop methylation (D-loop-met), relative mtDNA copy number (mtDNA-cn) and mtDNA oxidation (mtDNA-oxi) were investigated in DNA samples of individuals with MDD ( = 34), BD ( = 23), and healthy controls (HC; = 40) using the Real-Time Polymerase Chain Reaction (RT-PCR). Blood samples were obtained from a subset of individuals with MDD ( = 15) during a depressive episode (baseline) and after remission (8th week).

Results: The study groups exhibited significant differences in D-loop-met ( = 0.020), while relative mtDNA-cn and mtDNA-oxi showed comparable results. During the remission phase (8th week), there were lower levels of relative mtDNA-cn ( = -2.783, = 0.005) and D-loop-met ( = -3.180, = 0.001) compared to the acute MDD baseline, with no significant change in mtDNA-oxi levels ( = -1.193, = 0.233).

Conclusion: Our findings indicate significantly increased D-loop methylation in MDD compared to BD and HCs, suggesting distinct mtDNA modifications in these conditions. Moreover, the observed alterations in relative mtDNA-cn and D-loop-met during remission suggest a potential role of mtDNA alterations in the pathophysiology of MDD. Future studies may provide valuable insights into the dynamics of mtDNA modifications in both disorders and their response to treatment.

Citing Articles

Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review.

Gimenez-Palomo A, Andreu H, De Juan O, Olivier L, Ochandiano I, Ilzarbe L Brain Sci. 2025; 14(12.

PMID: 39766398 PMC: 11674880. DOI: 10.3390/brainsci14121199.


Prognostic Prediction and Immune Microenvironment Characterization in Uveal Melanoma: A Novel Mitochondrial Metabolism-Related Gene Signature.

Cai W, Chen R, Liu Z, Lai J, Hou L, Zhang R ACS Omega. 2024; 9(42):43034-43045.

PMID: 39464480 PMC: 11500162. DOI: 10.1021/acsomega.4c06294.


Integrating mitoepigenetics into research in mood disorders: a state-of-the-art review.

Ceylan D, Arat-Celik H, Aksahin I Front Physiol. 2024; 15:1338544.

PMID: 38410811 PMC: 10895490. DOI: 10.3389/fphys.2024.1338544.

References
1.
Malhi G, Mann J . Depression. Lancet. 2018; 392(10161):2299-2312. DOI: 10.1016/S0140-6736(18)31948-2. View

2.
van der Wijst M, van Tilburg A, Ruiters M, Rots M . Experimental mitochondria-targeted DNA methylation identifies GpC methylation, not CpG methylation, as potential regulator of mitochondrial gene expression. Sci Rep. 2017; 7(1):177. PMC: 5428053. DOI: 10.1038/s41598-017-00263-z. View

3.
Coppede F, Stoccoro A . Mitoepigenetics and Neurodegenerative Diseases. Front Endocrinol (Lausanne). 2019; 10:86. PMC: 6389613. DOI: 10.3389/fendo.2019.00086. View

4.
Kageyama Y, Deguchi Y, Kasahara T, Tani M, Kuroda K, Inoue K . Intra-individual state-dependent comparison of plasma mitochondrial DNA copy number and IL-6 levels in patients with bipolar disorder. J Affect Disord. 2021; 299:644-651. DOI: 10.1016/j.jad.2021.10.098. View

5.
Tsujii N, Otsuka I, Okazaki S, Yanagi M, Numata S, Yamaki N . Mitochondrial DNA Copy Number Raises the Potential of Left Frontopolar Hemodynamic Response as a Diagnostic Marker for Distinguishing Bipolar Disorder From Major Depressive Disorder. Front Psychiatry. 2019; 10:312. PMC: 6518968. DOI: 10.3389/fpsyt.2019.00312. View